Free shipping on all orders over $ 500

CH5132799

Cat. No. M1736

All AbMole products are for research use only, cannot be used for human consumption.

CH5132799 Structure
Synonym:

Izorlisib

Size Price Availability Quantity
1mg USD 75 In stock
5mg USD 170 In stock
10mg USD 280 In stock
50mg USD 860 In stock
100mg USD 1230 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

CH5132799 is a novel and potent class I PI3K inhibitor with IC50 value of 0.014 μM. The phosphatidylinositol 3-kinase (PI3K) pathway plays a central role in cell proliferation and survival in human cancer. In human tumor cell lines with PI3K pathway activation, CH5132799 showed potent antiproliferative activity. CH5132799 is orally available and showed significant antitumor activity in PI3K pathway-activated human cancer xenograft models in mice. CH5132799 selectively inhibited class I PI3Ks and PI3Kα mutants in vitro kinase assays. Moreover, CH5132799 did not reverse a negative feedback loop of PI3K/Akt/mTOR signaling and induced regression against tumors regrown after long-term mTORC1 inhibitor treatment.

Protocol (for reference only)
Cell Experiment
Cell lines breast, ovarian, prostate, and endometrial cancer cell lines
Preparation method Cell proliferation assay
The cell lines were added to the wells of 96-well plates containing 0.076 to 10,000 nmol/L CH5132799 and incubated at 37°C. After 4 days of incubation, Cell Counting Kit-8 solution (AbMole) was added and, after incubation for several more hours, absorbance at 450 nm was measured with Microplate-Reader iMark (Bio-Rad Laboratories). The antiproliferative activity was calculated by the formula (1 − T/C) × 100 (%), in which T and C represent absorbance at 450 nm of the cells treated with drugs (T) and that of untreated control cells (C). The IC50 values were calculated by using Microsoft Excel 2007.
Concentrations 0.076 to 10,000 nmol/L
Incubation time 4 days
Animal Experiment
Animal models mouse bearing xenograft model of breast cancer KPL-4(PIK3CA H1047R) and BT-474(PIK3CA K111N) and SKOV3 (PIK3CA H1047R)cells
Formulation saline
Dosages 12.5 mg/kg once a day
Administration orally
Chemical Information
Molecular Weight 377.42
Formula C15H19N7O3S
CAS Number 1007207-67-1
Solubility (25°C) DMSO 12 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Tanaka H, et al. Clin Cancer Res. The selective class I PI3K inhibitor CH5132799 targets human cancers harboring oncogenic PIK3CA mutations.

[2] Ohwada et al. Bioorg Med Chem Lett. Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799.

Related PI3K Products
AS605240

AS-605240 is a potent and selective inhibitor of PI 3-kinase γ (PI3Kγ) with an IC50 of 8 nM.

BEZ235

BEZ235 (NVP-BEZ235) is a potent dual PI3K and mTOR inhibitor of p110α, p110γ, p110δ and p110β with IC50 of 4 nM, 5 nM, 7 nM and 75 nM, respectively.

BKM120 (Buparlisib)

BKM120 (NVP-BKM120) is a potent and highly specific oral pan-class I PI3K inhibitor.

GDC-0941 (Pictilisib)

GDC-0941 is a selective and potent inhibitor of Class I PI3K, p110a IC50=0.003uM, U87MG IC50=0.95μM.

AS-252424

AS-252424 is a furan-2-ylmethylene thiazolidinedione as a selective ATP-competitive PI3Kγ inhibitor with IC50 with 33 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: CH5132799, Izorlisib supplier, PI3K, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.